SS-31 Peptide Dosage Chart: Research Protocols

At a glance: Preclinical SS-31 dosing parameters

Preclinical evaluation of SS-31 (Elamipretide) spans diverse laboratory models focusing on mitochondrial bioenergetics and cellular respiration. In rodent studies, daily administration schedules typically range from 1 mg/kg to 10 mg/kg depending on whether the target endpoint is acute ischemia-reperfusion or chronic metabolic research.

In vitro assays utilize concentrations between 1 nM and 10 μM to observe cardiolipin binding and reactive oxygen species (ROS) attenuation directly within isolated mitochondria. Reconstitution protocols require sterile bacteristatic water or phosphate-buffered saline (PBS) to achieve clear solution integrity.

To ensure precise volumetric calculations, investigators rely on analytical-grade material with verified lot purity above 98%. You can inspect third-party testing parameters or order 10 mg vials of SS-31 directly from the PX1 Research catalog.

What is SS-31 (Elamipretide) in laboratory research?

SS-31, chemically known as D-Arg-2',6'-Dmt-Lys-Phe-NH2 or Elamipretide, is a tetrapeptide engineered to selectively target the inner mitochondrial membrane. Unlike traditional antioxidants that scavenge free radicals indiscriminately throughout the cytosol, SS-31 binds directly to cardiolipin via electrostatic and hydrophobic interactions.

Cardiolipin is an essential phospholipid required for maintaining mitochondrial cristae structure and optimizing electron transport chain complexes. When cardiolipin undergoes peroxidation, electron transfer efficiency drops, leading to excessive superoxide production and reduced adenosine triphosphate (ATP) synthesis.

By stabilizing cardiolipin, SS-31 helps preserve cristae architecture and restores electron flux through Complex I and Complex III. Laboratory investigators frequently cross-reference SS-31 data with other mitochondrial-active compounds such as MOTS-c and Humanin to map distinct pathways of cellular energy modulation.

Preclinical SS-31 dosage chart by research objective

When referencing an ss 31 peptide dosage chart for animal models, protocols vary based on species, target tissue, and exposure duration. The following synthesis reflects published preclinical research literature for murine and cell-culture designs:

• In Vitro Mitochondrial Assays: 1 nM – 10 μM concentration in buffer; used for isolated mitochondrial swelling, membrane potential (ΔΨm), and ATP flux studies. • Acute Murine Ischemia Models: 1.0 mg/kg – 3.0 mg/kg administered intraperitoneally (IP) or intravenously (IV) 30 minutes prior to ischemia or immediately upon reperfusion. • Chronic Rodent Metabolic Models: 3.0 mg/kg – 10.0 mg/kg daily via subcutaneous (SC) injection over 4 to 12 weeks to assess renal, cardiovascular, or neurodegenerative biomarkers. • Tissue Culture Stress Response: 10 nM – 1 μM added to culture medium prior to oxidative stress challenge (e.g., hydrogen peroxide or hypoxia-reoxygenation).

Converting rodent doses to equivalent research calculations requires consideration of body surface area (BSA) scaling. For example, a 3 mg/kg daily dose in a mouse (~0.025 kg) equates to approximately 0.075 mg per subject daily. Researchers evaluating large cohorts can explore bulk options via our wholesale peptide portal to maintain batch consistency across extended studies.

Reconstitution math and concentration calculations for SS-31

Accurate dosing in laboratory settings depends on precise reconstitution technique. Lyophilized SS-31 acetate powder dissolves readily in aqueous media due to its hydrophilic tetrapeptide structure and basic amino acid side chains.

To reconstitute a standard 10 mg vial of SS-31 for animal administration, inject 2.0 mL of sterile bacteriostatic water or PBS into the vial using standard aseptic laboratory technique. Gently swirl the vial until the lyophilized cake dissolves completely; never vortex or shake vigorously, as mechanical shear can degrade peptide bonds.

This yields a stock solution concentration of 5 mg/mL (10 mg / 2.0 mL). If your animal protocol specifies a 0.3 mg dose per mouse, the required injection volume is calculated as: Volume = 0.3 mg / 5.0 mg/mL = 0.06 mL (60 microliters). Review our complete research peptide catalog for complementary reagents and diluents.

Administration routes and frequency in in vivo studies

In vivo literature details three primary routes of administration for SS-31: subcutaneous (SC), intraperitoneal (IP), and intravenous (IV). The selection of route dictates bioavailability kinetics and peak plasma concentration (Cmax).

Subcutaneous administration represents the most common route for chronic administration protocols. It provides steady absorption over several hours with minimal handling stress for the animal. Intraperitoneal injection is frequently selected for acute toxicity or short-term metabolic studies due to rapid absorption into the portal circulation.

Intravenous bolus or continuous infusion is reserved for acute ischemia-reperfusion experiments where immediate membrane integration is required. Regardless of route, daily dosing schedules are most prevalent in published papers owing to the elimination half-life of SS-31 in small mammals, which ranges from 2 to 4 hours.

Species-specific dose translation and allometric scaling

Translating dosing protocols across different animal species requires allometric scaling factors based on metabolic rate and body surface area, rather than simple weight-based linear extrapolation. The standard human equivalent dose (HED) conversion formula established by FDA guidelines relies on the Km factor (Body Weight kg / Surface Area m²).

For instance, the Km factor for a mouse is 3, whereas the Km factor for a rat is 6, and a human reference is 37. To convert a mouse dose of 10 mg/kg to a rat equivalent dose: Rat Dose (mg/kg) = Mouse Dose (10 mg/kg) × (Km mouse 3 / Km rat 6) = 5 mg/kg.

Understanding these scaling principles prevents under-dosing or off-target metabolic saturation in comparative species trials. Researchers conducting cross-species comparative analyses can reference technical documentation across our peptide research library.

Evaluating SS-31 quality: Key vendor verification criteria

Reliable preclinical results require analytical certainty regarding compound purity, identity, and biological stability. When sourcing SS-31, researchers must verify six distinct quality benchmarks before introducing material into experimental assays:

1. Purity Verification: High-Performance Liquid Chromatography (HPLC) testing must confirm purity ≥ 98.0%, ensuring the absence of truncated peptide sequences. 2. Mass Spectrometry (MS): Electrospray Ionization MS (ESI-MS) must verify the exact molecular mass of SS-31 (639.8 g/mol for the free base). 3. Endotoxin Data: Limulus Amebocyte Lysate (LAL) testing must confirm endotoxin levels below 0.05 EU/mg to prevent immune activation in animal models. 4. Sourcing & Synthesis: USA-based peptide synthesis ensures strict adherence to quality management systems. 5. Lot Traceability: Every vial must link directly to an accessible, lot-matched Certificate of Analysis (COA). 6. Domestic Shipping Speed: Rapid, climate-controlled domestic dispatch prevents freeze-thaw degradation during transit. Inspect verified batches and order 10 mg vials of SS-31.

Red flags when sourcing SS-31 for laboratory use

Sourcing peptides from unverified suppliers introduces significant experimental risks, including inconsistent assay results, cell toxicity, or unexplainable animal mortality. Investigators should avoid vendors that exhibit key operational red flags.

Watch for suppliers providing generic COAs that lack specific lot numbers, run dates, or raw chromatogram traces. A static PDF copied across multiple batches is a primary signal of unverified reselling.

Additionally, avoid vendors that fail to report endotoxin assay results. Residual lipopolysaccharides (LPS) from bacterial expression or improper processing can trigger severe inflammatory cytokines in cell and animal models, confounding mitochondrial research metrics. Always cross-reference compounds with known benchmarks like BPC-157 to ensure vendor compliance across their full catalog.

Ordering SS-31 from PX1 Research

PX1 Research is dedicated to supplying verified, high-purity research peptides to academic institutions, biotechnology firms, and independent laboratories across the United States. Our SS-31 (Elamipretide) is supplied in lyophilized, vacuum-sealed glass vials engineered for maximum shelf stability.

Orders placed before 3:00 PM EST Monday through Friday ship same-day from our fulfillment facilities in California and Arizona. Every order includes tracking details and direct digital access to lot-specific HPLC and MS analysis, verifying purity and sequence correctness prior to shipment.

Whether you require individual 10 mg vials for pilot testing or larger quantities for extended animal cohorts, PX1 Research delivers uncompromising quality and rapid customer support. Visit our main SS-31 product page to place your order or contact our technical team for custom laboratory inquiries.